Michael C. Gibson
Vorstandsvorsitzender bei The Baim Institute for Clinical Research
Profil
Michael C.
Gibson is currently the President & Chief Executive Officer at The Baim Institute for Clinical Research.
Prior to this, he was a Professor & Chairman-PERFUSE Study Group at Harvard Medical School from 2012.
He completed his undergraduate, graduate, and doctorate degrees from The University of Chicago.
Aktive Positionen von Michael C. Gibson
| Unternehmen | Position | Beginn |
|---|---|---|
The Baim Institute for Clinical Research
 The Baim Institute for Clinical Research Miscellaneous Commercial ServicesCommercial Services The Baim Institute for Clinical Research manages clinical trial data in a range of therapeutic areas for commercial, academic, and scientific purposes. The firm engages in the design, management, and data analysis of clinical trials in the U.S. and internationally. It offers clinical CRO services that include trial design, project management, site management and monitoring, statistical analysis, medical monitoring and oversight, clinical endpoint event identification and adjudication and medical writing services; and data management, including electronic data capture services. The company was founded by Donald S. Baim and Richard E. Kuntz in 1993 and is headquartered in Boston, MA. | Vorstandsvorsitzender | - |
| Harvard Medical School | Corporate Officer/Principal | 01.01.1987 |
Ausbildung von Michael C. Gibson
| The University of Chicago | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
The Baim Institute for Clinical Research
The Baim Institute for Clinical Research Miscellaneous Commercial ServicesCommercial Services The Baim Institute for Clinical Research manages clinical trial data in a range of therapeutic areas for commercial, academic, and scientific purposes. The firm engages in the design, management, and data analysis of clinical trials in the U.S. and internationally. It offers clinical CRO services that include trial design, project management, site management and monitoring, statistical analysis, medical monitoring and oversight, clinical endpoint event identification and adjudication and medical writing services; and data management, including electronic data capture services. The company was founded by Donald S. Baim and Richard E. Kuntz in 1993 and is headquartered in Boston, MA. | Commercial Services |
